Serpin C1/Antithrombin-III Antibody (OTI8D5) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74113APC
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # OTI8D5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length recombinant protein of human Serpin C1/Antithrombin-III (NP_000479) produced in HEK293T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Serpin C1/Antithrombin-III Antibody (OTI8D5) [Allophycocyanin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Serpin C1/Antithrombin-III
Alternate Names
Antithrombin-III, ATIII
Gene Symbol
SERPINC1
Additional Serpin C1/Antithrombin-III Products
Product Documents for Serpin C1/Antithrombin-III Antibody (OTI8D5) [Allophycocyanin]
Product Specific Notices for Serpin C1/Antithrombin-III Antibody (OTI8D5) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...